Summary of Treatment Guidelines for Systemic Diseases Related to Implant Therapy

Abstract

The following are guidelines on systemic diseases in accordance to enable more informed decisions to be made when treating oral implants.
1．It is important to prevent a silent pandemic because Antimicrobial Resistance (AMR) is projected to become the leading cause of mortality in 2050.
2．Amyloidosis is expected to be the leading cause of death in the older population. It is crucial to be attentive to carpal tunnel syndrome, a form of neuropathy, as it can serve as the initial indication of the disease.
3．Asthma often occurs for the first time in middle age, and an increasing number of patients have Chronic Obstructive Pulmonary Disease (COPD) as a co-morbid condition (Asthma/COPD Overlap Syndrome : ACO). Dental treatment of these patients should be prepared of the inhaled drug Short-acting β-agonists (SABA).
4．For chronic constipation, avoiding the use of stimulant laxatives is advisable whenever possible.
5．Obesity is a high risk for atherosclerotic disease ; therefore, prioritizing visceral fat reduction is more important.
6．An algorithm that prioritizes the concept of prescribing, rather than adhering to conventional guidelines, has been published and is considered a breakthrough in the management of type 2 diabetes mellitus.
7．Dyslipidemia is a latent disease, and risk management is necessary to prevent it from progressing to clinical inertia.
8．The association between periodontal disease and dementia and that between renal failure and dementia are increasingly evident, as is the interrelationship among each organ and each specific disease.
The process of oral implant treatment encompasses not only placement but also maintenance. Therefore, continuing lifelong intervention in accordance with the latest findings is necessary while accurately assessing the patient’s general condition.